Hide Board Information

Show Board Information

Oncotelic Therapeutics Inc. OTLC

Board Mod: ScottMyers911

Asst Mods:

Last Post: 04/05/2023 8:42:29 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 2

Oncotelic Therapeutics Inc. (OTCMRKTS: OTLC) Stock Message Board

1. OTLC Company Profile

    

2. OTLC Time & Sales

    

3. OTLC Recent News

    

4. OTLC Filings

    

5. OTLC Financials

    

6. OTLC Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

48	Oncotelic Announces Release of Pet2DAO Tokens	panda448	04/05/2023 8:42:29 PM
47	Oncotelic Awarded BARDA Funding for Development	panda448	10/17/2022 6:48:26 PM
46	Oncotelic Announces Pipeline Presentation and IPO	panda448	06/15/2022 5:04:02 PM
45	ONCOTELIC PROVIDES Q1 2022 FINANCIAL RESULTS	panda448	05/23/2022 1:25:35 PM
44	Oncotelic Appoints Fatih Uckun, M.D., Ph.D., as	panda448	05/04/2022 1:04:13 PM
43	Oncotelic Appoints Seymour Fein M.D. as Chief	panda448	05/04/2022 1:04:02 PM
42	Oncotelic; Announcing Successful Joint Venture	panda448	04/04/2022 4:19:15 PM
41	Oncotelic presentation at MedInvest	panda448	04/01/2022 2:21:28 PM
40	Oncotelic JV Financing:	panda448	03/21/2022 3:48:37 PM
39	Oncotelic; Looking at Industry Comparison for the	panda448	03/15/2022 7:42:49 PM
38	Oncotelic; Discussing the Company's Development	panda448	03/15/2022 7:40:57 PM
37	Oncotelic; Diving into the Company's Outlook for	panda448	03/15/2022 7:40:43 PM
36	Oncotelic to Present New Studies on its TGF-	panda448	03/10/2022 2:17:44 PM
35	Oncotelic; An Introduction to CFO Amit Shah & His	panda448	03/02/2022 6:00:46 PM
34	Oncotelic Initiates Phase 1 Trial Evaluating CA4P	panda448	01/05/2022 11:37:47 AM
33	Oncotelic Announces that ORF8 Mutations are	panda448	12/22/2021 11:34:33 AM
32	Oncotelics Dr. Anthony Maida to Present at 2nd	panda448	12/14/2021 12:07:13 PM
31	Mesothelioma Clinical Trial to Involve Drug	panda448	12/08/2021 7:37:25 PM
30	Oncotelic 2021 Q3 Report, Litchfield reiterates	panda448	12/07/2021 6:44:09 PM
29	Biotech Growth Stocks Set to Benefit from Rising	panda448	12/03/2021 7:26:03 PM
28	New Oncotelic Therapeutics Inc (OTLC) Stock	panda448	11/29/2021 6:33:47 PM
27	Oncotelic Therapeutics Inc (OTLC) stock news and	panda448	11/22/2021 7:55:18 PM
26	Oncotelic Announces Successful Completion of	panda448	11/16/2021 9:27:46 AM
25	Another TGF-beta acquisition- bode well for	panda448	11/10/2021 5:47:11 PM
24	$OTLC in immunotherapy space: Immunotherapy	panda448	11/05/2021 7:56:33 PM
23	ONCOTELIC ANNOUNCES UPDATE ON THE OT-101 CLINICAL	panda448	10/22/2021 8:15:01 PM
22	ONCOTELIC ACQUIRES FAST TO MARKET LATE-STAGE DRUG	panda448	10/05/2021 6:19:24 PM
21	OT-101 an antisense against TGF-2 for	panda448	09/29/2021 8:17:18 PM
20	ONCOTELIC TO ACQUIRE LATE-STAGE DRUG CANDIDATE	panda448	09/07/2021 6:46:29 PM
19	PULMOHEAL/ ARTIVEDA IS CLINICALLY ACTIVE	panda448	09/07/2021 6:45:04 PM
18	ONCOTELIC AND GOLDEN MOUNTAIN PARTNERS FORMING A	panda448	08/16/2021 7:04:07 PM
17	New 8-K	CaptnAmerca	07/20/2021 10:31:08 AM
16	ONCOTELIC CLOSES COVID-19 CLINICAL TRIAL EARLY	CaptnAmerca	06/15/2021 9:24:41 AM
15	Mateon Therapeutics Inc. has changed its name to	panda448	03/31/2021 3:24:28 PM
14	Litchfield Hills upgrade price target to $4 from	panda448	03/05/2021 2:04:49 PM
13	MATEON THERAPEUTICS AND WINDLAS BIOTECH PUBLISH	panda448	03/03/2021 8:41:37 PM
12	MATEON PARTNERED WITH CHOPRA FOUNDATION ON	panda448	02/16/2021 6:04:51 PM
11	Targeting TGF-b pathway with COVID-19 Drug	panda448	02/01/2021 6:05:26 PM
10	MATEON LAUNCHING MOBILE APP, ARTIHEALTH, FOR	panda448	01/26/2021 8:15:48 PM
9	Zacks Small Cap Research: MATN: POSITIVE INTERIM	panda448	01/14/2021 7:25:15 PM
8	MATEON ANNOUNCES POSITIVE INTERIM RESULTS FROM	panda448	01/13/2021 2:35:51 PM
7	Litchfield Hills Research MATN-Buy-$3 PT:	panda448	01/08/2021 1:53:46 PM
6	We might need to redefine our approach to drug	panda448	01/07/2021 7:02:27 PM
5	MATEONS GLOBAL STUDY FOR OT-101/ TGF-	panda448	12/30/2020 2:48:50 PM
4	Initiating coverage of MATN, Buy rating and $3	panda448	12/15/2020 1:17:00 PM
3	Positive early results in treating COVID-19:	panda448	12/15/2020 1:13:54 PM
2	$MATN New$$$	TonyCorvette	11/04/2020 7:41:50 AM
1	$MATN I LIKE	mick	08/23/2020 6:06:29 PM

Recent Articles

• Investors Eye Key Stock Movements in Leading Tech Companies
• Cultural Ties Strengthened: Chen Jinggu Festival Unites Regions
• DRC Medicine and Ribbon Acquisition Join Forces for Growth
• Rakovina Therapeutics Plans Amendments to Debentures and Warrants
• Raoul Pal Applauds Robinhood's Tokenized Stocks Revolution
• Dyne Therapeutics Sets $200 Million Common Stock Offering
• Dyne Therapeutics Secures $200 Million in Stock Offering
• Cathie Wood's Strategic Shifts: Focusing on AMD and Exiting Coinbase
• Growing Movement for Child Care Solutions Gains Momentum
• Growing Initiative Calls for Solutions to Child Care Needs
• Exploring AI's Impact on Culture Through Art and Reflection
• Sarepta Therapeutics Faces Class Action Amid Safety Concerns
• Investigation into GoHealth and Others Sparks Investor Interest
• Legal Actions Impacting Hims & Hers Health Shareholders
• Acceleware's Innovative Strategy for Debt Reduction and Growth
• Investigating The MathWorks, Inc. Data Breach Claims
• Understanding Class Action Lawsuits and Their Impact on Investors
• Insights into Apple and Sable Investigations and Impacts
• Investors Need to Know About Recent Class Actions Against Major Companies
• Investor Alert: Class Action Lawsuits Against Multiple Firms
• Meta's Innovations in VR: The Future of Mobile Technology
• Acceleware Initiates Non-Brokered Placement to Innovate Technology
• Understanding the Class Action Against DoubleVerify Holdings, Inc.
• Shell Takes Major Step Forward with Innovative LNG Project
• Celebrating Healthier Choices through the ADD MILK! Campaign Success
• UroGen Pharma's Future Hinges on URGN Class Action Details
• Understanding the Securities Claims Against TechTarget Inc.
• Red Cat Holdings: Key Updates and Investor Notices Unveiled
• Silver Viper Minerals Boosts Private Placement to $3.6M
• Explore the Latest Summer 2025 Diamond Certified Directory Update
• NMP Acquisition Corp. Sets Stage for $100 Million IPO Success
• Western Uranium & Vanadium Engages New Transfer Agent Following AGM
• Mesoblast Approaches FDA Approval for Groundbreaking Therapy
• Oliveda International, Inc. Expands Waterless Beauty to Canada
• Organon & Co. Investors Alert: Class Action Filing Reminder
• Krispy Kreme: Faced with Legal Actions and Market Fluctuations
• Swiss Water Secures Warrant Purchase from Mill Road Capital
• Exploring Breakthroughs in Space Tech: Rocket Lab and AST SpaceMobile
• Achieve Life Sciences Secures $45 Million in Stock Offering
• Class Action Update for Sarepta Therapeutics Investors
• Purpose Investments Inc. Unveils New Distribution Schedule 2025
• Amazing Growth of HCA Healthcare Revealed Over a Decade
• PepGen Inc. Faces Class Action: Investor Counsel Alert
• The Growth Journey of a $100 HubSpot Investment Over Five Years
• Investors Should Stay Alert: Petco Class Action Insights
• Celebrating Excellence: Robert Michael & Co.'s Real Estate Triumph
• Tam Fortis Innovations in Nuclear Power Solutions for Tomorrow
• Syria's Sanction Lift: A New Chapter in Economic Progress
• Robert Michael & Co.: Celebrating Success and New Listings
• Unlocking the Growth Potential of Primerica Stock Investment